Annual RAS-Targeted Drug Development Summit on September 24-26, 2024 in Boston, United States
- Event Type: Conference
- Presentation: Physical
- Website URL: http://go.evvnt.com/2464057-0?pid=10008
- Contact E-mail: [email protected]
- Location: Boston, United States
- Venue: Hilton Boston Park Plaza
- Date: September 24-26, 2024
- Organization: Hanson Wade Group
- Conference Tags: science health medicine pharmaceuticals drug development
Uniting Large Pharma, Innovative Biotech and Leading Academics to Defeat the Holy Grail Target in Precision Oncology
With tumor and patient heterogeneity, the quest to target the remaining RAS mutants continues, and now more than ever, we are witnessing this industry make great strides in utilizing novel modalities and elucidating mechanisms of resistance. However, treating patients with RAS mutant cancers remains no easy feat, as knowledge gaps persist in improving the depth and durability of response, tackling emerging resistance mechanisms and informing combination strategies to improve the standard-of care for patients in need.
Owing to this, the 6th Annual RAS-Targeted Drug Development Summit returns as the central hub dedicated to every aspect of discovery and development of RAS, from discovery and clinical development through to commercialization, equipping 200+ global RAS leaders with the means to create effective frontline RAS therapies for better patient outcomes.
URLs:
Tickets: https://go.evvnt.com/2464057-2?pid=10008
Brochure: https://go.evvnt.com/2464057-3?pid=10008
Time: 8:00 AM - 4:45 PM
Prices:
Conference + Workshop - Drug Developer Pricing: USD 4197.00,
Conference Only - Drug Developer Pricing: USD 2999.00,
Conference + Workshop - Solution and Service Provider Pricing: USD 5097.00,
Conference Only - Solution and Service Provider Pricing: USD 3699.00,
Conference + Workshop - Academic and Non-Profit Pricing: USD 3597.00,
Conference Only - Academic and Non-Profit Pricing: USD 2599.00
Speakers: Ahmadur Rahman, Senior Clinical Director and Clinical Science Lead, Global Oncology Research and Development, Roche, Andrea Wang-Gillam, Chief Medical Officer, Jacobio Pharmaceuticals, Andreas Weiss, Associate Director, Norvartis, Andrew Norris, Co-Founder and Chief Scientific Officer, BCN Biosciences, Bhakti Mehta, Executive Medical Director, Amgen, Bobby Norgard, Senior Scientist, Boehringer Ingelheim, Bradley Quade, Senior Scientist, Nested Therapeutics, Brent Kreider, President, Biomed Valley Discoveries, Brian Lanman, Senior Director - Research, Amgen, Chiara Ambrogio, Associate Professor of Molecular Biology, University of Turin, Chinatsu Sakata-Sakurai, Vice President, Primary Focus Lead, Targeted Protein Degradation, Astellas Pharma, Christopher Hupp, Senior Director - External Innovation, Chemistry, Ipsen, Eric Campeau, Vice President Translational Research, Thryv Therapeutics, Eric Haines, Director - Scientific Cancer Biology, Ikena Oncology, Geoff Oxnard, Vice President, Clinical Development, Global Head, Thoracic Cancer, Loxo@Lilly, Henning Lauterbach, Vice President, Immunology Research and Clinical Biomarkers, Hookipa Pharma, Hetika Patel, Scientist, Kura Oncology, Jan Smith, Chief Scientific Officer, Revolution Medicines, Ji Luo, Senior Investigator and Head, Oncogenic Signaling Section, National Cancer Institute, Joe Klebba, Associate Director, Vividion Therapeutics, John Hayslip, Chief Medical Officer, Verastem, Jonathan Pachter, Chief Scientific Officer, Verastem, Joseph Mancias, Assistant Professor of Radiation Oncology, Harvard Medical School, Kevin Foley, Co-founder and Chief Scientific Officer, Ranok Therapeutics, Kevin Webster, Chief Scientific Officer, Frontier Medicines, Krzysztof Brzozka, Chief Scientific Officer, Executive Vice President, Ryvu Therapeutics, Lynn Kirkpatrick, Chief Executive Officer, PHusis Therapeutics, Madhumita Bogdan, Senior Principal Investigator, Biological Sciences, Deciphera Pharmaceuticals, Markus Vallaster, Vice President - Clinical Development, Affini-T Therapeutics, Naftali Bechar, Senior Vice President - Clinical Development, Inspirna, Nathan Jameson, Senior Scientist, Zentalis Pharmaceuticals, Peter DeMuth, Chief Scientific Officer, Elicio Therapeutics, Qiang Lu, Co-Founder and Chairman, GenFleet Therapeutics, Rafael Rosengarten, Chief Executive Officer, Genialis, Reagan Jarvis, Co-founder, CEO, Anocca, Shailaja Kasibhatla, Senior Vice President, Boundless Bio, Sunanda Singh, Founder and Chief Executive Officer. Singh Biotechnology, Wolfgang Schwede, Principal Scientist, Bayer, Yu Wang, Chief Medical Officer, GenFleet Therapeutics, Zahra Kabiri, Assistant Professor, Duke University
Name: Hanson Wade Group
Address: 52 Grosvenor Gardens
- November 18, 2024 International Conference on Medical and Health Sciences (ICMHS) - Singapore, Singapore
- December 23, 2024 International Conference on Ultrasonics (ICU) - Barcelona, Spain
- December 16, 2024 International Conference on Medical and Health Sciences (ICMHS) - Vientiane, Laos
- September 26, 2024 International Conference on Medical and Health Sciences (ICMHS) - San Francisco, United States
- November 04, 2024 International Conference on Oncology (ICO) - Amsterdam, Netherlands
- December 02, 2024 International Conference on Ultrasonics (ICU) - Tokyo, Japan
- November 04, 2024 International Conference on Hematology (ICH) - Cape Town, South Africa
- December 02, 2024 International Conference on Oncology (ICO) - Auckland, New Zealand
- October 17, 2024 International Conference on Neurology and Epidemiology (ICNE) - Kathmandu, Nepal
- September 16, 2024 International Conference on Anesthesiology and Critical Care Medicine (ICACCM) - Santiago, Chile
- October 28, 2024 International Conference on Medical and Health Sciences (ICMHS) - Lisbon, Portugal
- December 16, 2024 International Conference on Neurology and Epidemiology (ICNE) - Vientiane, Laos
- October 28, 2024 International Conference on Pediatrics (ICP) - Lisbon, Portugal
- December 02, 2024 International Conference on Neurology and Epidemiology (ICNE) - Auckland, New Zealand
- December 02, 2024 International Conference on Oncology (ICO) - Sydney, Australia
- December 02, 2024 International Conference on Pediatrics (ICP) - Amsterdam, Netherlands
- September 16, 2024 International Conference on Neurology and Epidemiology (ICNE) - Paris, France
- December 30, 2024 International Conference on Medical and Health Sciences (ICMHS) - Paris, France
- October 17, 2024 International Conference on Medical and Health Sciences (ICMHS) - London, United Kingdom
- September 26, 2024 International Conference on Hematology (ICH) - Istanbul, Turkey
- November 07, 2024 International Conference on Cardiology and Cardiac Surgery (ICCCS) - Tokyo, Japan
- September 19, 2024 International Conference on Ultrasonics (ICU) - Toronto, Canada
- October 24, 2024 International Conference on Pediatrics (ICP) - Bali, Indonesia
- December 09, 2024 International Conference on Ultrasonics (ICU) - London, United Kingdom
- September 19, 2024 International Conference on Oncology (ICO) - Toronto, Canada
- November 11, 2024 International Conference on Medical and Health Sciences (ICMHS) - Jeddah, Saudi Arabia
- December 16, 2024 International Conference on Cardiology and Cardiac Surgery (ICCCS) - Vientiane, Laos
- October 17, 2024 International Conference on Cardiology and Cardiac Surgery (ICCCS) - London, United Kingdom
- December 30, 2024 International Conference on Cardiology and Cardiac Surgery (ICCCS) - Honolulu, United States
- December 23, 2024 International Conference on Hematology (ICH) - Istanbul, Turkey
- October 17, 2024 International Conference on Hematology (ICH) - Kathmandu, Nepal
- September 26, 2024 International Conference on Anesthesiology and Critical Care Medicine (ICACCM) - San Francisco, United States
- September 12, 2024 International Conference on Pediatrics (ICP) - Singapore, Singapore
- November 04, 2024 International Conference on Anesthesiology and Critical Care Medicine (ICACCM) - Nicosia, Cyprus
- October 17, 2024 International Conference on Anesthesiology and Critical Care Medicine (ICACCM) - London, United Kingdom
- November 25, 2024 International Conference on Medical and Health Sciences (ICMHS) - London, United Kingdom
- September 12, 2024 International Conference on Hematology (ICH) - Singapore, Singapore
- November 18, 2024 International Conference on Cardiology and Cardiac Surgery (ICCCS) - Kyoto, Japan
- November 07, 2024 International Conference on Anesthesiology and Critical Care Medicine (ICACCM) - New York, United States
- October 03, 2024 International Conference on Hematology (ICH) - Tokyo, Japan
- September 19, 2024 International Conference on Oncology (ICO) - Lisbon, Portugal
- September 26, 2024 International Conference on Medical and Health Sciences (ICMHS) - Vancouver, Canada
- December 16, 2024 International Conference on Ultrasonics (ICU) - Vientiane, Laos
- November 25, 2024 International Conference on Neurology and Epidemiology (ICNE) - Bangkok, Thailand
- December 02, 2024 International Conference on Medical and Health Sciences (ICMHS) - Sydney, Australia
- December 30, 2024 International Conference on Anesthesiology and Critical Care Medicine (ICACCM) - Karachi, Pakistan
- September 12, 2024 International Conference on Ultrasonics (ICU) - New York, United States
- October 10, 2024 International Conference on Oncology (ICO) - Rome, Italy
- November 07, 2024 International Conference on Cancer Science (ICCS) - Tokyo, Japan
- November 25, 2024 International Conference on Pediatrics (ICP) - Bangkok, Thailand
- September 11, 2024 Pre Filled Syringes Connect - Boston, United States
- September 09, 2024 Wearable Injectors and Connected Devices - Boston, United States
- September 09, 2024 ADC and Radiopharmaceuticals Pharma and Biotech Partnering Summit - Boston, United States
- September 10, 2024 GxP Cloud Compliance Summit - Boston, United States
- September 10, 2024 Gene Therapy for Ophthalmic Disorders Summit - Boston, United States
- September 11, 2024 Optimizing Hybrid Clinical Trials Summit - Boston, United States
- September 17, 2024 Principles of Critical Care Medicine for Non-Intensive Care Specialists - Boston, United States
- September 17, 2024 CAR-TCR Summit - Boston, United States
- September 17, 2024 CRISPR-Based Therapy Analytical Development Summit - Boston, United States
- September 17, 2024 Exosome-Based Therapeutic Development Summit - Boston, United States